First AD

Second AD

Implementing Updates to AML Classification Guidelines

Video content above is prompted by the following:

Briefly provide an overview of secondary AML.

What is the pathogenesis of this disease?

Please briefly discuss the updates to European LeukemiaNet and World Health Organization classifications for defining secondary AML.

How have the updates to classification guidelines impacted how you diagnose and classify secondary AML patients?

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Video Series

Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration 

Panelists discuss how secondary acute myeloid leukemia (AML) presents unique challenges in diagnosis, classification, and treatment due to its complex pathogenesis and evolving classification criteria.